Literature DB >> 2460118

The relative effects of digoxin and diltiazem upon ventricular ectopic activity in patients with chronic atrial fibrillation.

R V Lewis1, D G McDevitt.   

Abstract

In eight patients with chronic atrial fibrillation, treatment with digoxin (plasma drug concentration 1.3 to 2.0 nmol l-1) was associated with a significantly higher incidence of ventricular premature beats (VPBs) (mean 22.8 h-1) than diltiazem 120 mg three times daily (mean 6.8 h-1) (P less than 0.05). Seven out of the eight patients showed an increase in numbers of VPBs recorded over 24 h during treatment with digoxin when compared with diltiazem. The clinical importance of these results is unclear, but atrial fibrillation and ischaemic heart disease frequently co-exist, and increases in ventricular ectopy may predispose to serious ventricular arrhythmias following myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460118      PMCID: PMC1386546          DOI: 10.1111/j.1365-2125.1988.tb05284.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

Review 1.  Digitalis intoxication in patients with atrial fibrillation.

Authors:  J A Kastor
Journal:  Circulation       Date:  1973-04       Impact factor: 29.690

2.  A study of ventricular ectopy during atrial fibrillation.

Authors:  N Rapeport; L Schamroth
Journal:  Heart Lung       Date:  1985-03       Impact factor: 2.210

3.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

4.  A comparison of verapamil and digoxin in the treatment of atrial fibrillation.

Authors:  R Lewis; M Lakhani; T A Moreland; D G McDevitt
Journal:  Eur Heart J       Date:  1987-02       Impact factor: 29.983

5.  Effect of a digitalis drug on ventricular premature beats.

Authors:  B Lown; T B Graboys; P J Podrid; B H Cohen; M B Stockman; C E Gaughan
Journal:  N Engl J Med       Date:  1977-02-10       Impact factor: 91.245

6.  Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study.

Authors:  J E Muller; Z G Turi; P H Stone; R E Rude; D S Raabe; A S Jaffe; H K Gold; N Gustafson; W K Poole; E Passamani; T W Smith; E Braunwald
Journal:  N Engl J Med       Date:  1986-01-30       Impact factor: 91.245

7.  Immediate effects of intravenous verapamil in cardiac arrhythmias.

Authors:  L Schamroth; D M Krikler; C Garrett
Journal:  Br Med J       Date:  1972-03-11

8.  Ventricular premature beats and mortality after myocardial infarction.

Authors:  W Ruberman; E Weinblatt; J D Goldberg; C W Frank; S Shapiro
Journal:  N Engl J Med       Date:  1977-10-06       Impact factor: 91.245

9.  The role of Holter monitoring in detecting digitalis-provoked arrhythmias.

Authors:  C Goren; P Denes
Journal:  Chest       Date:  1981-05       Impact factor: 9.410

10.  Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin.

Authors:  C DeCarli; G Sprouse; J C LaRosa
Journal:  Am J Cardiol       Date:  1986-04-15       Impact factor: 2.778

View more
  2 in total

Review 1.  Atrial fibrillation. The therapeutic options.

Authors:  R V Lewis
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

2.  Oral magnesium reduces ventricular ectopy in digitalised patients with chronic atrial fibrillation.

Authors:  R V Lewis; B Tregaskis; J McLay; E Service; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.